Skip to main content
. 2023 Oct 10;40(12):2885–2894. doi: 10.1007/s10815-023-02956-z

Table 2.

Maternal complications and perinatal outcomes in the three groups

HMG (n = 918) LE + HMG (n = 341) HRT (n = 1451) p value HMG vs. LE + HMG HMG vs. HRT HRT vs. LE + HMG
Maternal complications
 GDM (%) 98 (10.7) 40 (11.7) 132 (9.1) 0.232
 HDP (%) 71 (7.7) 20 (5.9) 140 (9.6) 0.046* 0.255 0.111 0.027*
 PPH (%) 1 (0.1) 1 (0.3) 6 (0.4) 0.399
 Abnormal placentation (%) 8 (0.9) 1 (0.3) 16 (1.1) 0.364
 Oligohydramnios (%) 10 (1.1) 2 (0.6) 18 (1.2) 0.582
 Polyhydramnios (%) 2 (0.2) 1 (0.3) 4 (0.2) > 0.999
 Mode of delivery (%) 0.013* 0.975 0.007* 0.052
  Vaginal 263 (28.6) 98 (28.7) 344 (23.7)
  Cesarean delivery 655 (71.4) 243 (71.3) 1107 (76.3)
 Gestational age (weeks) 38.29 ± 1.79 38.31 ± 2.35 38.43 ± 1.64 0.184
Neonatal outcomes
 Sex of neonate (%) 0.290
  Male 480 (52.3) 174 (51.0) 798 (55.0)
  Female 435 (47.4) 164 (48.1) 642 (44.2)
  Unknown 3 (0.3) 3 (0.9) 11 (0.8)
 Birth weight (g) 3434.2 ± 557.0 3412.8 ± 591.2 3480.9 ± 576.5 0.051
 Weight category (%)
  < 1500 g 5 (0.5) 5 (1.5) 17 (1.2) 0.211
  1500–2500 g 47 (5.1) 15 (4.4) 53 (3.7) 0.223
  4000–4500 g 132 (14.4) 46 (13.5) 239 (16.5) 0.227
  > 4500 g 15 (1.6) 6 (1.8) 31 (2.1) 0.668
 SGA (%) 17 (1.9) 9 (2.6) 18 (1.2) 0.147
 LGA (%) 293 (31.9) 96 (28.2) 534 (36.8) 0.002* 0.199 0.015* 0.003*
 Stillbirth (%) 3 (0.3) 3 (0.9) 11 (0.8) 0.354
 Preterm birth (%) 86 (9.4) 36 (10.6) 140 (9.6) 0.817

HMG human menopausal gonadotropin, LE letrozole, HRT hormone replacement therapy, GDM gestational diabetes mellitus, HDP hypertensive disorders of pregnancy, PPH postpartum hemorrhage, SGA small for gestational age, LGA large for gestational age

Abnormal placentation includes placenta previa, placental abruption, and placenta implantation

*p-value < 0.05 was considered as statistically significant